Phosphate in early chronic kidney disease - associations with clinical outcomes and a target to reduce cardiovascular risk
Nephrology,  Clinical Article

Toussainti ND et al. – High phosphate levels in chronic kidney disease (CKD) have been associated with increased all–cause mortality and cardiovascular morbidity and mortality. Observational studies have also demonstrated a consistent relationship between serum phosphate in the normal range and all–cause and cardiovascular mortality, left ventricular hypertrophy (LVH) and decline in renal function. Furthermore, fibroblast growth factor–23, a phosphaturic hormone, increases very early in the course of CKD and is strongly associated with death and cardiovascular disease, including LVH and vascular calcification.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Nursing

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nursing Articles

Indexed Journals in Nursing: Journal of Advanced Nursing, Journal of Clinical Nursing, Nurse Education In Practicemore